is fda stopping tirzepatide NO longer in SHORTAGE. What You Need to Know Trade association opposes FDA decision

Like GLP-1 receptor agonists, tirzepatide carries an FDA-mandated black box warning for patients with a personal or family history of medullary thyroid cancer or who have multiple endocrine neoplasia syndrome type 2

Sitagliptin and Metformin Immediate-Release Coadministration in Patients with Type 2 Diabetes Inadequately Controlled on Diet and Exercise Table 1 summarizes the most common (5% of patients) adverse reactions reported (regardless of investigator assessment of causality) in a 24-week placebo-controlled factorial study in which sitagliptin and metformin immediate-release were coadministered to patients with type 2 diabetes inadequately controlled on diet and exercise

Biochem Pharmacol

Arapis, K

If you are ready to find out whether B12 deficiency may be contributing to your symptoms, scheduling a consultation is a straightforward first step